BIOMAT Database Logo BIOMAT Database Logo

The augmented blood pressure response to chronic angiotensin II infusion in partially nephrectomized rats. 1993

M Yasujima, and M Kanazawa, and K Yoshida, and M Kohzuki, and H Watanabe, and M Hiwatari, and T Sato, and K Abe
Institute of Rehabilitation Medicine, Tohoku University School of Medicine, Narugo, Japan.

To assess potential roles of circulating levels of angiotensin II (Ang II) in the regulation of blood pressure in rats with reduced functional renal mass, we studied the blood pressure response to chronic infusion of Ang II at a subpressor dose in partially nephrectomized rats. Male Sprague-Dawley rats were subjected to 1/6, 2/6, 3/6, 4/6 and 5/6 nephrectomy, and sham operation a week before the infusion of Ang II at a rate of 400 micrograms/kg/day delivered intraperitoneally by osmotic minipumps for 14 days, or vehicle alone served as controls. Infusion of Ang II was associated with a slight but significant increase in systolic blood pressure in 1/6 nephrectomized rats (p < 0.05), whereas it did not induce a significant change in systolic blood pressure in sham-operated rats. Hypertension during Ang II infusion was more prominent in 2/6 nephrectomized rats than that in 1/6 nephrectomized rats (p < 0.05). However, there was no significant difference in hypertension during Ang II infusion among groups in 2/6, 3/6, 4/6 and 5/6 nephrectomized rats. Blood urea nitrogen and serum creatinine levels, endogenous creatinine clearance, urinary excretion of protein as indices of renal function, and urinary sodium excretion were not affected by chronic infusion of Ang II in 1/6, 2/6, 3/6, 4/6 and 5/6 nephrectomized, and sham-operated rats. There was also no significant difference in circulating levels of Ang II among Ang II infused-groups in 1/6 and 2/6 nephrectomized rats. These results indicate that elevated levels of circulating Ang II are capable of causing a sustained hypertension in rats with reduced functional renal mass.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D008297 Male Males
D009318 Natriuresis Sodium excretion by URINATION. Natriureses
D009392 Nephrectomy Excision of kidney. Heminephrectomy,Heminephrectomies,Nephrectomies
D011507 Proteinuria The presence of proteins in the urine, an indicator of KIDNEY DISEASES. Proteinurias
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D001806 Blood Urea Nitrogen The urea concentration of the blood stated in terms of nitrogen content. Serum (plasma) urea nitrogen is approximately 12% higher than blood urea nitrogen concentration because of the greater protein content of red blood cells. Increases in blood or serum urea nitrogen are referred to as azotemia and may have prerenal, renal, or postrenal causes. (From Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, 1984) BUN,Nitrogen, Blood Urea,Urea Nitrogen, Blood
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine

Related Publications

M Yasujima, and M Kanazawa, and K Yoshida, and M Kohzuki, and H Watanabe, and M Hiwatari, and T Sato, and K Abe
The blood pressure response following angiotensin in nephrectomized, urethanized rats.
January 1970, Acta pharmacologica et toxicologica,
M Yasujima, and M Kanazawa, and K Yoshida, and M Kohzuki, and H Watanabe, and M Hiwatari, and T Sato, and K Abe
Sex-differences in circadian blood pressure variations in response to chronic angiotensin II infusion in rats.
April 2008, Clinical and experimental pharmacology & physiology,
M Yasujima, and M Kanazawa, and K Yoshida, and M Kohzuki, and H Watanabe, and M Hiwatari, and T Sato, and K Abe
Blood pressure response to the portal infusion of angiotensin-II.
January 1966, Surgical forum,
M Yasujima, and M Kanazawa, and K Yoshida, and M Kohzuki, and H Watanabe, and M Hiwatari, and T Sato, and K Abe
The blood pressure effect of angiotensin in nephrectomized rats.
January 1970, Acta pharmacologica et toxicologica,
M Yasujima, and M Kanazawa, and K Yoshida, and M Kohzuki, and H Watanabe, and M Hiwatari, and T Sato, and K Abe
Augmented vascular response of the nephrectomized rat to angiotensin.
November 1972, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
M Yasujima, and M Kanazawa, and K Yoshida, and M Kohzuki, and H Watanabe, and M Hiwatari, and T Sato, and K Abe
Augmented Blood Pressure Variability in Hypertension Induced by Angiotensin II in Rats.
February 2016, American journal of hypertension,
M Yasujima, and M Kanazawa, and K Yoshida, and M Kohzuki, and H Watanabe, and M Hiwatari, and T Sato, and K Abe
The response of blood pressure to infusion of angiotensin II: relation to plasma concentrations of renin and angiotensin II.
April 1972, Clinical science,
M Yasujima, and M Kanazawa, and K Yoshida, and M Kohzuki, and H Watanabe, and M Hiwatari, and T Sato, and K Abe
The adrenocortical response to angiotensin II infusion in anephric and non-nephrectomized patients on regular hemodialysis.
January 1977, Acta medica Scandinavica,
M Yasujima, and M Kanazawa, and K Yoshida, and M Kohzuki, and H Watanabe, and M Hiwatari, and T Sato, and K Abe
Cisplatin-induced nephrotoxicity alters blood pressure response to angiotensin II administration in rats.
January 2016, Advanced biomedical research,
M Yasujima, and M Kanazawa, and K Yoshida, and M Kohzuki, and H Watanabe, and M Hiwatari, and T Sato, and K Abe
Exaggerated blood pressure response to exercise is associated with augmented rise of angiotensin II during exercise.
July 2008, Journal of the American College of Cardiology,
Copied contents to your clipboard!